glp-1 kidney disease Potential kidney-protective and other effects of receptor Discoveries in Medicine - GLP-1

They may recommend dose changes, supportive medications, or a different treatment altogether based on your feedback

Specifically, semaglutide and tirzepatide, along with diet and exercise, are indicated for weight loss and have been shown to reduce body weight by up to 20%

As with other drugs, some of the effects are desirable, and some are not

For example, if a medication has a half-life of 6 days , that means 50% of the drug is gone 6 days after the injection , 75% is gone by day 12, and so on

After 72 weeks, weight loss averaged 5.5 percent at 6 mg, 7.8 percent at 12 mg, and 10.5 percent at 36 mg

Wegovy at Endocare is also available, alongside Mounjaro